ARTIVA BIOTHERAPEUTICS INC (ARTV) Stock News
NASDAQ:ARTV - Nasdaq - US04317A1079 - Common Stock - Currency: USD
ARTV Latest News, Press Relases and Analysis
Artiva Biotherapeutics to Participate in the TD Cowen 45th Annual Health Care Conference
SAN DIEGO, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Artiva Biotherapeutics, Inc. (Nasdaq: ARTV), a clinical-stage biotechnology company whose mission is to...
Artiva Biotherapeutics to Participate in the TD Cowen 45th Annual Health Care Conference
Artiva Biotherapeutics Expands Board of Directors with Appointment of Dan Baker, M.D.
SAN DIEGO, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Artiva Biotherapeutics, Inc. (Nasdaq: ARTV), a clinical-stage biotechnology company whose mission is to...
Artiva Biotherapeutics Announces Pricing of Upsized $167.0 Million Initial Public Offering
Artiva Biotherapeutics Announces Pricing of Upsized $167.0 Million Initial Public Offering ...
Artiva Biotherapeutics Expands Board of Directors with Appointment of Dan Baker, M.D.
Artiva Biotherapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights
Expanded Board of Directors with appointment of Dr. Alison Moore bringing cell therapy and manufacturing expertise to advance AlloNK® in autoimmune...
Artiva Biotherapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights
Artiva Biotherapeutics to Participate in the Jefferies London Healthcare Conference
SAN DIEGO, Nov. 11, 2024 (GLOBE NEWSWIRE) -- Artiva Biotherapeutics, Inc. (Nasdaq: ARTV), a clinical-stage biotechnology company whose mission is to...
Artiva Biotherapeutics to Participate in the Jefferies London Healthcare Conference
Artiva Biotherapeutics Appoints Alison Moore, Ph.D., to Its Board of Directors
Artiva Biotherapeutics Appoints Alison Moore, Ph.D., to Its Board of Directors...
Artiva Biotherapeutics Appoints Alison Moore, Ph.D., to Its Board of Directors
Artiva Biotherapeutics to Participate in the 2024 Cantor Fitzgerald Global Healthcare Conference
Artiva Biotherapeutics to Participate in the 2024 Cantor Fitzgerald Global Healthcare Conference...
Artiva Biotherapeutics to Participate in the 2024 Cantor Fitzgerald Global Healthcare Conference
Artiva Biotherapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights
Artiva Biotherapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights...
Artiva Biotherapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights
This Biotech IPO Stock Aims to Seize a Multibillion-Dollar Market with Its Innovative Treatment
Artiva's revolutionary cell therapies could be a patient lifeline and a goldmine for investors.
This Biotech IPO Stock Aims to Seize a Multibillion-Dollar Market with Its Innovative Treatment
Artiva's revolutionary cell therapies could be a patient lifeline and a goldmine for investors.
Artiva Shares Jump 30% After Upsized $167 Million US IPO
Artiva Biotherapeutics Inc. shares jumped 30% in the company’s trading debut after raising $167 million in an expanded initial public offering.
GC-Backed Artiva Biotherapeutics Raises $167 Million in US IPO
Artiva Biotherapeutics Inc., a clinical stage biotechnology company backed by South Korea’s Green Cross Corp., raised $167 million in an initial public offering, expanding the size of the share sale.
